Genomic Cancer Panel And Profiling Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities
We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
#What Is the Current and Projected Market Size of the Genomic Cancer Panel And Profiling Market Through 2034?#_x000D_
In the past few years, the market size for genomic cancer panel and profiling has witnessed a significant growth. It is predicted to rise from $9.47 billion in 2024 to $10.31 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. The historical growth can be linked to factors such as the increasing global cancer incidences, the rising application in clinical trials, the broadening of diagnostic infrastructure, expanding knowledge of genetic testing, as well as enhanced government and research funding._x000D_
_x000D_
The market for genomic cancer panel and profiling is slated to experience robust expansion in the coming years. The market value is predicted to hit $14.37 billion in 2029, with a compound annual growth rate (CAGR) of 8.7%. This predicted progression during the forecast period is linked to the broadening of liquid biopsy applications, increased usage for early detection, the rise of personalized therapies, and a surge in companion diagnostics approvals. Key trends expected during this period involve the incorporation of AI and machine learning for the interpretation of genomic data, the development of multi-omics strategies, the advent of cloud-based genomic data storage and analysis, integration with electronic health records, and the growth of next-generation sequencing (NGS) platforms._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=24225&type=smp_x000D_
_x000D_
#What Are the Core Market Drivers Propelling Growth in the Genomic Cancer Panel And Profiling Industry?#_x000D_
The projected increase in cancer rates is predicted to fuel the expansion of the market for genomic cancer panels and profiling. Cancer is a medical condition typified by the abnormal and unrestrained proliferation and distribution of cells in the body. The rising prevalence of cancer can be tied to factors like an aging population, contributing to an increased likelihood of cancer development as people’s lifespan increases. In the context of cancer, genomic cancer panels and profiling are leveraged to detect genetic irregularities and biomarkers, facilitating personalized treatment strategies and augmenting early detection and disease surveillance. For example, the American Cancer Society, a nonprofit organization based in the U.S., reported in January 2024 that around 20 million new cancer cases surfaced worldwide in 2022, causing 9.7 million fatalities. Primarily attributed to population growth, the worldwide cancer burden is anticipated to escalate to 35 million instances by 2050. Consequently, the upswing in cancer prevalence is set to fuel the growth of the genomic cancer panel and profiling market._x000D_
_x000D_
#How Is the Genomic Cancer Panel And Profiling Market Segmented?#_x000D_
The genomic cancer panel and profiling market covered in this report is segmented –_x000D_
_x000D_
1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing_x000D_
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies_x000D_
3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel_x000D_
4) By Application: Clinical, Research_x000D_
5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues_x000D_
2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=24225&type=smp_x000D_
_x000D_
#Which Regions Are Driving the Next Phase of the Genomic Cancer Panel And Profiling Market Growth?#_x000D_
North America was the largest region in the genomic cancer panel and profiling market in 2024. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#What Key Market Trends and Innovations Are Shaping the Future of the Genomic Cancer Panel And Profiling Industry?#_x000D_
In the genomic cancer panel and profiling market, leading firms are concentrating on technological innovations such as next-generation sequencers to enhance the precision, pace, and coverage of cancer diagnostics, and to facilitate more tailored treatment decisions. Next-generation sequencers are sophisticated DNA sequencing technologies that allow swift, large-scale analysis of genetic material for the detection of mutations, variations, and other genomic features. For example, in April 2025, the Netherlands’ biotechnology firm, QIAGEN N.V., introduced QIAseq panels specifically developed for next-generation sequencers, analyzing over 700 genes for comprehensive genomic profiling. These panels aim to ameliorate cancer diagnostics and treatment plans and are devised for both research and clinical implementations._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#How Is the Genomic Cancer Panel And Profiling Market Defined and What Are Its Core Parameters?#_x000D_
Genomic cancer panel and profiling is a molecular diagnostic technique that analyzes multiple genes simultaneously to detect genetic mutations, alterations, or biomarkers associated with cancer. Its primary purpose is to guide personalized treatment decisions, predict disease progression, and improve cancer diagnosis and monitoring._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=24225&type=smp_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 3156230293_x000D_
Asia +44 2071930708_x000D_
Europe +44 2071930708_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
